192 related articles for article (PubMed ID: 31813263)
41. [Clostridium difficile infections in geriatric patients].
Simmerlein R; Basta A; Gosch M
Z Gerontol Geriatr; 2016 Dec; 49(8):743-761. PubMed ID: 27785569
[TBL] [Abstract][Full Text] [Related]
42. Working out the bug in the accordion.
Chandok N; Kamath PS
Gastroenterology; 2009 Jul; 137(1):e5-6. PubMed ID: 19501204
[No Abstract] [Full Text] [Related]
43. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF
BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433
[TBL] [Abstract][Full Text] [Related]
44. "Collateral damage": antibiotics and the risk of Clostridium difficile infection.
Yam FK; Smith KM
Orthopedics; 2005 Mar; 28(3):275-9. PubMed ID: 15790086
[TBL] [Abstract][Full Text] [Related]
45. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis.
Friedman G
Gastroenterol Clin North Am; 2012 Dec; 41(4):763-79. PubMed ID: 23101686
[TBL] [Abstract][Full Text] [Related]
46. Recent changes in Clostridium difficile infection.
Silva Júnior M
Einstein (Sao Paulo); 2012; 10(1):105-9. PubMed ID: 23045838
[TBL] [Abstract][Full Text] [Related]
47. Clostridium difficile colitis: a review.
Moudgal V; Sobel JD
Hosp Pract (1995); 2012 Feb; 40(1):139-48. PubMed ID: 22406889
[TBL] [Abstract][Full Text] [Related]
48. Acute primary abdominal compartment syndrome due to Clostridium difficile induced toxic megacolon: a case report and review of the literature.
Carmeliet T; Zachée P; Dits H; Regenmortel N; Malbrain M
Anaesthesiol Intensive Ther; 2019; 51(4):273-282. PubMed ID: 31741357
[TBL] [Abstract][Full Text] [Related]
49. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
Lo Vecchio A; Zacur GM
Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
[TBL] [Abstract][Full Text] [Related]
50. Current knowledge on the laboratory diagnosis of
Martínez-Meléndez A; Camacho-Ortiz A; Morfin-Otero R; Maldonado-Garza HJ; Villarreal-Treviño L; Garza-González E
World J Gastroenterol; 2017 Mar; 23(9):1552-1567. PubMed ID: 28321156
[No Abstract] [Full Text] [Related]
51. [Treatment of refractory or recurrent Clostridium difficile infection].
Kim SW
Korean J Gastroenterol; 2012 Aug; 60(2):71-8. PubMed ID: 22926117
[TBL] [Abstract][Full Text] [Related]
52. Clostridioides difficile and colorectal cancer: a dangerous liaison.
Bassotti G; Stracci F; Marconi P; Fettucciari K
Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):985-988. PubMed ID: 37505976
[TBL] [Abstract][Full Text] [Related]
53. Recent trends in the epidemiology and treatment of C. difficile infection in children.
Sammons JS; Toltzis P
Curr Opin Pediatr; 2013 Feb; 25(1):116-21. PubMed ID: 23241874
[TBL] [Abstract][Full Text] [Related]
54. Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics.
Kim JS; Ward KK; Shah NR; Saenz CC; McHale MT; Plaxe SC
Support Care Cancer; 2013 Nov; 21(11):3103-7. PubMed ID: 23839499
[TBL] [Abstract][Full Text] [Related]
55. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
[TBL] [Abstract][Full Text] [Related]
56. Association between Antibiotic Consumption and Incidence of
Kim B; Kim J; Pai H
J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370
[TBL] [Abstract][Full Text] [Related]
57. A case-control study of community-associated Clostridium difficile infection.
Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
[TBL] [Abstract][Full Text] [Related]
58. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
59. A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
Sedigh Ebrahim-Saraie H; Heidari H; Amanati A; Bazargani A; Alireza Taghavi S; Nikokar I; Kalantar K; Motamedifar M
Infez Med; 2018 Dec; 26(4):308-315. PubMed ID: 30555133
[TBL] [Abstract][Full Text] [Related]
60. Molecular Epidemiology and Risk Factors of
Yang Z; Huang Q; Qin J; Zhang X; Jian Y; Lv H; Liu Q; Li M
Front Cell Infect Microbiol; 2020; 10():578098. PubMed ID: 33425775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
